Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad.p53 DC Vaccine and Indoximod in Metastatic Solid Tumors and Breast Cancer
NCT01042535Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Dec 2009
- Primary completion
- Dec 2014
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indoximod, Ad.p53-DC vaccine in solid tumor, breast cancer, sponsored by Moffitt Cancer Center. Started Dec 2009; status: completed.
02
Drugs
indoximodAd.p53-DC vaccine
03
Conditions
solid tumorbreast cancer
Beyond the preview
Go deeper on NCT01042535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01042535.